Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Objective: To determine fibrinolytic activity and exercise stimulated fibrinolytic capacity in patients with type 2 diabetes mellitus at diagnosis and after 12 months treatment aimed at improving glycaemic control. Subjects: Thirteen patients referred to the hospital diabetic out-patient department with a new diagnosis of type 2 diabetes mellitus were selected for study. Methods: Basal fibrinolytic activity and exercise stimulated fibrinolytic capacity were measured at diagnosis and after 12 months of interventional therapy. Results: Compared with controls basal fibrinolytic activity was depressed in the diabetic patients due to increased levels of PAI-1:Ag 15.1(4.6-20) versus 8.4 (3.0-9.9) ng/ml, p<0.05 and PAI,17.6 (10.9-26.8) versus 6.6 (4.8-13.6) IU/ml, p<0.01. PAI was related to fasting plasma insulin levels r=0.8, p<0.001 and body mass index r=0.7, p<0.01 at diagnosis, but not triglycerides or blood pressure. Median t-PA:Ag was also elevated in the diabetic group 9.8 (6.3-12.1) versus 4.5 (3.1-7.1) ng/ml, p<0.001. The percentage change in ECLT with exercise was inversely proportional to the degree of insulin resistance r=-0.08, p<0.001 and fasting plasma insulin r=-0.65, p--0.02, at diagnosis. Despite an improvement in glycosylated haemoglobin, 8.7 (1.8) to 7.0 (1.2) %, p=0.008, over 12 months, the ECLT increased from 290 (220-315) to 360 (316-375) mins, p<0.05. This was associated with an increase in the PAI-1:Ag/t-PA:Ag ratio from 1.92 (1.63) to 2.48 (0.97), p=0.025. Although t-PA release due to exercise was reduced in the diabetic group (38%) compared to non-diabetic controls (82%) p<0.001, similar results were found after 12 months 54.5% to those at diagnosis 38%, (NS). Conclusion: This study has shown that in a selective group of type 2 diabetic patients, exercise stimulated fibrinolytic capacity is maintained over a 12 month period despite a deterioration in basal fibrinolytic activity. © 1994.

Original publication




Journal article


Fibrinolysis and Proteolysis

Publication Date





372 - 377